Library licensing deal sends shares in Xenova soaring

Shares in Xenova, the biotechnology group which floated at 215p in December, soared 80p to 435p yesterday after it announced a licensing deal with Zeneca for its library of naturally occurring compounds. The news comes less than two months after Xenova clinched a similar research collaboration with Bristol-Myers Squibb, the big US pharmaceuticals group.

The biotech company refused to reveal the financial details of the link- up with Zeneca, which paid pounds 2m for a 4 per cent stake at the time of the float, but Louis Nisbet, chief executive, said it was part of Xenova's "enormous progress" over the past year.

He said the company's QTC libraries, which are derived from plant, fungal and microbial sources, "provide the fastest way of unlocking pharmaceutical products of interest from natural products chemistry". Because of the way they are formatted, these libraries can be shipped to pharmaceuticals companies which can use them to test potential drug targets.

Zeneca will pay an initial licence fee to use the libraries, then milestone fees for every lead it takes up and royalties on any drugs which result from the collaboration. The latest biotech tie-up is the third for Zeneca since last June, following so-called database subscription agreements with Incyte Pharmaceuticals of California and Pharmacopeia of New Jersey.

The news came as Xenova announced a small cut in losses from pounds 7.99m to pounds 7.77m for the year to December, on revenues cut from pounds 1.79m to pounds 1.59m. It started the year with pounds 27.8m net cash, including pounds 21.3m from the placing and is set to pick up pounds 2m under a deal with Warner Lambert shortly.

Separately, Cambridge Antibody Technology announced that its flotation later this month would be priced at 500p, capitalising the group at pounds 109m. The biotechnology company is raising pounds 38m, after expenses, from the placing, with first dealings expected to begin on Tuesday. David Chiswell, chief executive, said the company would use the money to develop CAT's portfolio of antibody-based human therapeutic products.

Also yesterday, Cantab Pharmaceuticals announced its anti-herpes vaccine had been well tolerated in early stage trials. The drug, which formed the centrepiece of a licensing deal with Glaxo Wellcome on Tuesday, was being tested in 24 carriers of the disease in the UK.

Start your day with The Independent, sign up for daily news emails
Sport
football This was Kane’s night, even if he played just a small part of it
Travel
travel Dreamland Margate, Britain’s oldest amusement park, is set to reopen
News
news
News
Founders James Brown and Tim Southwell with a mock-up of the first ever ‘Loaded’ magazine in 1994
media
News
Threlfall says: 'I am a guardian of the reality keys. I think I drive directors nuts'
people
Voices
voices The group has just unveiled a billion dollar plan to help nurse the British countryside back to health
News
The Westgate, a gay pub in the centre of Gloucester which played host to drag queens, has closed
news
ebooks
ebooksA special investigation by Andy McSmith
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Retirement Coordinator - Financial Services

Negotiable: Recruitment Genius: To provide a prompt, friendly and efficient se...

Recruitment Genius: Annuities / Pensions Administrator

Negotiable: Recruitment Genius: You will be the first point of contact for all...

Ashdown Group: HR, Payroll & Benefits Officer - Altrincham - up to £24,000.

£18000 - £24000 per annum + benefits: Ashdown Group: HR, Payroll & Benefits Of...

Ashdown Group: Learning and Development Programme Manager

£35000 - £38000 per annum + benefits : Ashdown Group: A highly successful, int...

Day In a Page

The saffron censorship that governs India: Why national pride and religious sentiment trump freedom of expression

The saffron censorship that governs India

Zareer Masani reveals why national pride and religious sentiment trump freedom of expression
Prince Charles' 'black spider' letters to be published 'within weeks'

Prince Charles' 'black spider' letters to be published 'within weeks'

Supreme Court rules Dominic Grieve's ministerial veto was invalid
Distressed Zayn Malik fans are cutting themselves - how did fandom get so dark?

How did fandom get so dark?

Grief over Zayn Malik's exit from One Direction seemed amusing until stories of mass 'cutting' emerged. Experts tell Gillian Orr the distress is real, and the girls need support
The galaxy collisions that shed light on unseen parallel Universe

The cosmic collisions that have shed light on unseen parallel Universe

Dark matter study gives scientists insight into mystery of space
The Swedes are adding a gender-neutral pronoun to their dictionary

Swedes introduce gender-neutral pronoun

Why, asks Simon Usborne, must English still struggle awkwardly with the likes of 's/he' and 'they'?
Disney's mega money-making formula: 'Human' remakes of cartoon classics are part of a lucrative, long-term creative plan

Disney's mega money-making formula

'Human' remakes of cartoon classics are part of a lucrative, long-term creative plan
Lobster has gone mainstream with supermarket bargains for £10 or less - but is it any good?

Lobster has gone mainstream

Anthea Gerrie, raised on meaty specimens from the waters around Maine, reveals how to cook up an affordable feast
Easter 2015: 14 best decorations

14 best Easter decorations

Get into the Easter spirit with our pick of accessories, ornaments and tableware
Paul Scholes column: Gareth Bale would be a perfect fit at Manchester United and could turn them into serious title contenders next season

Paul Scholes column

Gareth Bale would be a perfect fit at Manchester United and could turn them into serious title contenders next season
Inside the Kansas greenhouses where Monsanto is 'playing God' with the future of the planet

The future of GM

The greenhouses where Monsanto 'plays God' with the future of the planet
Britain's mild winters could be numbered: why global warming is leaving UK chillier

Britain's mild winters could be numbered

Gulf Stream is slowing down faster than ever, scientists say
Government gives £250,000 to Independent appeal

Government gives £250,000 to Independent appeal

Donation brings total raised by Homeless Veterans campaign to at least £1.25m
Oh dear, the most borrowed book at Bank of England library doesn't inspire confidence

The most borrowed book at Bank of England library? Oh dear

The book's fifth edition is used for Edexcel exams
Cowslips vs honeysuckle: The hunt for the UK’s favourite wildflower

Cowslips vs honeysuckle

It's the hunt for UK’s favourite wildflower
Child abuse scandal: Did a botched blackmail attempt by South African intelligence help Cyril Smith escape justice?

Did a botched blackmail attempt help Cyril Smith escape justice?

A fresh twist reveals the Liberal MP was targeted by the notorious South African intelligence agency Boss